HUE050810T2 - Faecalibacterium prausnitzii CNCM 1-4573 törzse gyomor-bélrendszeri gyulladás kezelésére és megelõzésére - Google Patents

Faecalibacterium prausnitzii CNCM 1-4573 törzse gyomor-bélrendszeri gyulladás kezelésére és megelõzésére

Info

Publication number
HUE050810T2
HUE050810T2 HUE17702322A HUE17702322A HUE050810T2 HU E050810 T2 HUE050810 T2 HU E050810T2 HU E17702322 A HUE17702322 A HU E17702322A HU E17702322 A HUE17702322 A HU E17702322A HU E050810 T2 HUE050810 T2 HU E050810T2
Authority
HU
Hungary
Prior art keywords
prevention
treatment
faecalibacterium prausnitzii
gastrointestinal inflammation
strain cncm
Prior art date
Application number
HUE17702322A
Other languages
English (en)
Hungarian (hu)
Inventor
Philippe Langella
Rosique Rebeca Martin
Humaran Luis Bermudez
Florian Chain
Harry Sokol
Original Assignee
Institut National De Rech Pour Lagriculture
Univ Sorbonne
Hopitaux Paris Assist Publique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National De Rech Pour Lagriculture, Univ Sorbonne, Hopitaux Paris Assist Publique filed Critical Institut National De Rech Pour Lagriculture
Publication of HUE050810T2 publication Critical patent/HUE050810T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204Probiotics, living bacteria to be ingested for action in the digestive tract
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
HUE17702322A 2016-01-25 2017-01-23 Faecalibacterium prausnitzii CNCM 1-4573 törzse gyomor-bélrendszeri gyulladás kezelésére és megelõzésére HUE050810T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1650567A FR3046934B1 (fr) 2016-01-25 2016-01-25 Souche de faecalibacterium prausnitzii cncm i-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale

Publications (1)

Publication Number Publication Date
HUE050810T2 true HUE050810T2 (hu) 2021-01-28

Family

ID=55862967

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE17702322A HUE050810T2 (hu) 2016-01-25 2017-01-23 Faecalibacterium prausnitzii CNCM 1-4573 törzse gyomor-bélrendszeri gyulladás kezelésére és megelõzésére

Country Status (17)

Country Link
US (1) US10918678B2 (enExample)
EP (1) EP3407902B1 (enExample)
JP (1) JP6935632B2 (enExample)
CN (1) CN109310714A (enExample)
AU (1) AU2017211244B2 (enExample)
CA (1) CA3012214C (enExample)
ES (1) ES2820338T3 (enExample)
FR (1) FR3046934B1 (enExample)
HU (1) HUE050810T2 (enExample)
IL (1) IL260752B (enExample)
LT (1) LT3407902T (enExample)
NZ (1) NZ744528A (enExample)
PL (1) PL3407902T3 (enExample)
PT (1) PT3407902T (enExample)
SG (1) SG11201806361PA (enExample)
WO (1) WO2017129515A1 (enExample)
ZA (1) ZA201805302B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10010412B2 (en) * 2011-07-27 2018-07-03 Edwards Lifesciences Corporation Conical crimper
TWI778083B (zh) * 2017-06-16 2022-09-21 日商表飛鳴製藥股份有限公司 脂肪關連疾患及/或炎症的預防或治療劑
FR3084255B1 (fr) * 2018-07-26 2020-07-03 Institut National De La Recherche Agronomique (Inra) Souche de streptococcus thermophilus cnrz160 pour le traitement et la prevention de l'inflammation intestinale et des desordres associes, chez un individu
FR3099053B1 (fr) * 2019-07-24 2023-01-20 Inst Nat De La Rech Agronomique Inra Souches bacteriennes pour le traitement et la prevention d’une inflammation gastro-intestinale
EP3838276A1 (en) 2019-12-17 2021-06-23 Exeliom Biosciences Association of faecalibacterium prausnitzii strain cncm i-4573 with pentasa® for the treatment and prevention of gastrointestinal inflammation
KR102169795B1 (ko) * 2020-06-24 2020-10-27 주식회사 엔테로바이옴 신규한 피칼리박테리움 프로스니치 eb-fpdk9 균주 및 그의 용도
KR102169794B1 (ko) * 2020-06-24 2020-10-27 주식회사 엔테로바이옴 신규한 피칼리박테리움 프로스니치 균주 eb-fpdk11 및 그의 용도
EP4180051A4 (en) * 2020-07-13 2024-07-17 Ajou University Industry-Academic Cooperation Foundation Composition for preventing or treating inflammatory bowel disease
JP7535174B2 (ja) * 2020-08-14 2024-08-15 コバイオラブス,インコーポレーテッド フィーカリバクテリウムプラウスニッツィ菌株およびその用途
JP7570506B2 (ja) * 2020-09-28 2024-10-21 シージェイ バイオサイエンス, インク. 微生物を含む炎症性疾患の診断または治療用組成物
CN112402459B (zh) * 2020-10-27 2023-01-31 江南大学 普拉梭菌缓解过敏性哮喘和鼻炎Th2反应中的应用
KR102245415B1 (ko) * 2020-12-14 2021-04-29 주식회사 엔테로바이옴 피칼리박테리움 프로스니치 균주 배양 배지 조성물
EP4166150A1 (en) 2021-10-15 2023-04-19 Exeliom Biosciences Association of a faecalibacterium prausnitzii strain and anti-pd-1, anti-pd-l1 or anti-ctla-4 antibodies for the treatment of cancer
EP4389134A1 (en) * 2022-12-20 2024-06-26 Exeliom Biosciences Faecalibacterium prausnitzii strain cncm i-4573 for the treatment and prevention of clostridioides difficile infection
CN118845848B (zh) * 2024-07-01 2025-10-17 温州大学 普氏粪杆菌dsm 17677在制备防治猪流行性腹泻病毒感染产品中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015011700A (es) * 2013-03-05 2016-07-20 Univ Groningen Uso de la bacteria faecalibacterium prausnitzii htf-f (dsm 26943) para suprimir la inflamacion.
WO2016075294A1 (en) * 2014-11-13 2016-05-19 Institut National De La Recherche Agronomique (Inra) Faecalibacterium prausnitzii strains for treating and preventing gastrointestinal pain

Also Published As

Publication number Publication date
JP2019508486A (ja) 2019-03-28
AU2017211244A1 (en) 2018-08-09
US20190030089A1 (en) 2019-01-31
NZ744528A (en) 2020-02-28
EP3407902B1 (fr) 2020-07-15
CN109310714A (zh) 2019-02-05
CA3012214C (fr) 2024-09-17
ZA201805302B (en) 2019-10-30
IL260752B (en) 2021-02-28
FR3046934B1 (fr) 2018-01-26
FR3046934A1 (fr) 2017-07-28
WO2017129515A1 (fr) 2017-08-03
CA3012214A1 (fr) 2017-08-03
PT3407902T (pt) 2020-09-03
PL3407902T3 (pl) 2021-04-06
JP6935632B2 (ja) 2021-09-15
SG11201806361PA (en) 2018-08-30
BR112018015121A2 (pt) 2018-12-11
LT3407902T (lt) 2020-12-28
US10918678B2 (en) 2021-02-16
EP3407902A1 (fr) 2018-12-05
AU2017211244B2 (en) 2019-05-16
ES2820338T3 (es) 2021-04-20

Similar Documents

Publication Publication Date Title
ZA201805302B (en) Faecalibacterium prausnitzii strain cncm 1-4573 for the treatment and prevention of gastrointestinal inflammation
PL3218524T3 (pl) Szczepy faecalibacterium prausnitzii do leczenia i zapobiegania bólowi przewodu pokarmowego
PL3212208T3 (pl) Zastosowanie bakterii l. reuteri do zapobiegania lub leczenia dysbiozy mikrobioty we wczesnych fazach życia
IL258881A (en) Faecalibacterium prausnitzii and desulfovibrio piger for use in the treatment or prevention of diabetes and bowel diseases
EP2994161A4 (en) Probiotic prevention and treatment of colon cancer
PL3442547T3 (pl) Lactobacillus reuteri mm4-1a do zastosowania w leczeniu lub profilaktyce zaburzeń ze spektrum autyzmu
DK3484585T4 (en) Use of probiotics in the treatment and/or prevention of atopic dermatitis
SG11201504542PA (en) Probiotic strains for the treatment and/or prevention of diarrhœa
EP3634434A4 (en) TREATMENT AND DETECTION OF DYSBIOSIS
SG11202005526WA (en) Peptide immunogens of il-31 and formulations thereof for the treatment and/or prevention of atopic dermatitis
EP3579837C0 (en) AXITINIB, NINTEDANIB OR LENVATINIB FOR THE TREATMENT OF ROSACEA AND ATOPIC DERMATITIS
EP3186394A4 (en) Treatment and detection of melanoma
IL250450A0 (en) A new Bacillus type bacterium and its uses
PL3197556T3 (pl) KOMPOZYCJA DO ZAPOBIEGANIA l/LUB LECZENIA OBJAWÓW ALERGII
IL252779B (en) Prevention and treatment of inflammatory diseases
EP3661532B8 (en) Methylococcus capsulatus for use in the treatment or prevention of gastrointestinal dysbiosis
ZA201802501B (en) Antagonists of il-17c for the treatment and/or prevention of atopic dermatitis
EP3307143A4 (en) Atr-ftir for non-invasive detection of colitis
GB201617715D0 (en) Methods for the treatment and prevention of ebola
EP3104940A4 (en) Compositions and methods for the prevention and/or treatment of schistosomiasis
HK40009553A (en) Prevention and treatment of diabetic nephropathy
AU2014904752A0 (en) Methods for the treatment and prevention of iron overload
GB201617591D0 (en) Methods for the treatment and prevention of ebola
GB201617590D0 (en) Methods for the treatment and prevention of ebola
AU2014903347A0 (en) Treatment and detection of melanoma